Ara
Toplam kayıt 2, listelenen: 1-2
Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy
(Sage Publications Ltd, 2018)
Background: The primary objective of our study was to examine the clinical outcomes and prognosis of patients with metastatic renal cell carcinoma (mRCC) with brain metastases (BMs) receiving targeted therapy. Patients and ...
Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results
(Oxford University Press, 2018)
...